CASE REPORT article
Front. Vet. Sci.
Sec. Zoological Medicine
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1544599
This article is part of the Research TopicInsights in Veterinary Pharmacology and Toxicology: 2024View all 10 articles
Case series: Effects of an induced molting protocol using levothyroxine in five captive banded penguins (genus Spheniscus)
Provisionally accepted- 1Kangwon National University, Chuncheon, Republic of Korea
- 2Aquaplanet, Yeosu, Republic of Korea
- 3Jeonbuk National University, Jeonju, North Jeolla, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Penguin molts occur annually after breeding, allowing effective waterproofing and temperature regulation. However, aberrant molts frequently occur in penguins, which can lead to health problems if prolonged. Although the exact mechanisms underlying molting in birds remain unclear, some studies have focused on the roles of thyroid and sex hormones in penguins. Previous studies on forced molting using hormonal treatments have shown both success and failure. In particular, the use of synthetic thyroxine (levothyroxine) has mostly not been successful. This study aimed to induce molting by administering commercial levothyroxine to one Humboldt penguin (Spheniscus humboldti) and four African penguins (Spheniscus demersus) with abnormal molting, housed in aquaria. The planned levothyroxine dosing protocol was to start with 25 µg/kg PO q24h for 7 d, then increase it gradually to 50 µg/kg PO q24h for the next 7 d and 75 µg/kg PO q24h for 7 d, followed by a gradual decrease to 50 µg/kg PO q24h for 7 d, and 25 µg/kg PO q24h for the final 7 d. Three penguins received treatment according to this scheduled protocol, two of which initiated molting during the dosing period, while the third began to molt approximately 3 months post-treatment. Another penguin was administered the maximum dose for an additional week, which led to molting in the final week of treatment. In the remaining penguin, the medication was deemed to be insufficiently absorbed because of inadequate drug delivery methods. Consequently, the drug delivery strategy was changed during the 5th week of treatment, and the treatment was extended for an additional 3 weeks beyond the original plan, after which the penguin began to molt. Therefore, all five penguins in this study exhibited molting following oral levothyroxine treatment, suggesting that this is a potential option for inducing molting in banded penguins (Spheniscus sp.) experiencing aberrant molt.
Keywords: Humboldt penguins, African penguins, abnormal molt, forced-molt, Levothyroxine
Received: 13 Dec 2024; Accepted: 25 Aug 2025.
Copyright: © 2025 Park, Seo, Kim and Kang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Sang Wha Kim, Kangwon National University, Chuncheon, Republic of Korea
Yeong-Hun Kang, Jeonbuk National University, Jeonju, 561-756, North Jeolla, Republic of Korea
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.